647 related articles for article (PubMed ID: 28678401)
1. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
[TBL] [Abstract][Full Text] [Related]
2. Variation in cisplatinum sensitivity is not associated with Fanconi Anemia/BRCA pathway inactivation in head and neck squamous cell carcinoma cell lines.
Snyder ER; Ricker JL; Chen Z; Waes CV
Cancer Lett; 2007 Jan; 245(1-2):75-80. PubMed ID: 16466850
[TBL] [Abstract][Full Text] [Related]
3. Analysis of a FANCE Splice Isoform in Regard to DNA Repair.
Bouffard F; Plourde K; Bélanger S; Ouellette G; Labrie Y; Durocher F
J Mol Biol; 2015 Sep; 427(19):3056-73. PubMed ID: 26277624
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
[TBL] [Abstract][Full Text] [Related]
5. The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi Anemia (FA) E3 ligase complex to promote the FA DNA repair pathway.
Polito D; Cukras S; Wang X; Spence P; Moreau L; D'Andrea AD; Kee Y
J Biol Chem; 2014 Mar; 289(10):7003-7010. PubMed ID: 24451376
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Fanconi anemia genes and the risk of esophageal cancer.
Akbari MR; Malekzadeh R; Lepage P; Roquis D; Sadjadi AR; Aghcheli K; Yazdanbod A; Shakeri R; Bashiri J; Sotoudeh M; Pourshams A; Ghadirian P; Narod SA
Hum Genet; 2011 May; 129(5):573-82. PubMed ID: 21279724
[TBL] [Abstract][Full Text] [Related]
8. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.
Chandrasekharappa SC; Lach FP; Kimble DC; Kamat A; Teer JK; Donovan FX; Flynn E; Sen SK; Thongthip S; Sanborn E; Smogorzewska A; Auerbach AD; Ostrander EA;
Blood; 2013 May; 121(22):e138-48. PubMed ID: 23613520
[TBL] [Abstract][Full Text] [Related]
9. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Fanconi anemia genes in sporadic head and neck squamous cell carcinoma.
Wreesmann VB; Estilo C; Eisele DW; Singh B; Wang SJ
ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):218-25. PubMed ID: 17409780
[TBL] [Abstract][Full Text] [Related]
11. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
Kachnic LA; Li L; Fournier L; Willers H
Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
[TBL] [Abstract][Full Text] [Related]
13. Defects in the Fanconi Anemia Pathway and Chromatid Cohesion in Head and Neck Cancer.
Stoepker C; Ameziane N; van der Lelij P; Kooi IE; Oostra AB; Rooimans MA; van Mil SE; Brink A; Dietrich R; Balk JA; Ylstra B; Joenje H; Feller SM; Brakenhoff RH
Cancer Res; 2015 Sep; 75(17):3543-53. PubMed ID: 26122845
[TBL] [Abstract][Full Text] [Related]
14. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
[TBL] [Abstract][Full Text] [Related]
15. Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling.
Romick-Rosendale LE; Hoskins EE; Privette Vinnedge LM; Foglesong GD; Brusadelli MG; Potter SS; Komurov K; Brugmann SA; Lambert PF; Kimple RJ; Virts EL; Hanenberg H; Gillison ML; Wells SI
Clin Cancer Res; 2016 Apr; 22(8):2062-73. PubMed ID: 26603260
[TBL] [Abstract][Full Text] [Related]
16. Insights into Fanconi Anaemia from the structure of human FANCE.
Nookala RK; Hussain S; Pellegrini L
Nucleic Acids Res; 2007; 35(5):1638-48. PubMed ID: 17308347
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia.
Rickman KA; Lach FP; Abhyankar A; Donovan FX; Sanborn EM; Kennedy JA; Sougnez C; Gabriel SB; Elemento O; Chandrasekharappa SC; Schindler D; Auerbach AD; Smogorzewska A
Cell Rep; 2015 Jul; 12(1):35-41. PubMed ID: 26119737
[TBL] [Abstract][Full Text] [Related]
18. The fanconi anemia pathway limits human papillomavirus replication.
Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of mutations in FANCL gene: a second case of Fanconi anemia belonging to FA-L complementation group.
Ali AM; Kirby M; Jansen M; Lach FP; Schulte J; Singh TR; Batish SD; Auerbach AD; Williams DA; Meetei AR
Hum Mutat; 2009 Jul; 30(7):E761-70. PubMed ID: 19405097
[TBL] [Abstract][Full Text] [Related]
20. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
